Lys-Arg-Pro-Hyp-Gly-
Phe-Ser-Pro-Phe-Arg (M.W. 1204.4) C56H85N17O13 M. Sasaguri, M. Ikeda, M. Ideishi, and K. Arakawa, Biochem. Biophys. Res. Commun., 150, 511 (1988). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Springer-Verlag, Berlin, 1970. (Review) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Suppl., Springer-Verlag, Berlin, 1979. (Review)
Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg (M.W. 1204.4) C56H85N17O13 M. Sasaguri, M. Ikeda, M. Ideishi, and K. Arakawa, Biochem. Biophys. Res. Commun., 150, 511 (1988). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Springer-Verlag, Berlin, 1970. (Review) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Suppl., Springer-Verlag, Berlin, 1979. (Review)
![Lysyl-[Hyp3]-Bradykinin (Human) (0.5 mg vial) - PBK-4191-v - 1 Ea - Peptides International, Inc.](https://partimages.globalspec.com/28/4628/1869628_medium.png)
